DNLI SBC to Revenue

Denali Therapeutics Inc · SBC to Revenue

DNLI logo

DNLI SBC to Revenue

Latest reported635.82%
DNLI Quarterly SBC/Revenue (0.00% → 635.82%)
High-resolution chart · PNG

DNLI sbc to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Denali Therapeutics Inc SBC to Revenue — Quarterly
Period endingSBC to Revenue
635.8213%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
2,167.3244%
0%
79.918%
0%
0%
0%
0%
0%
0%
0%
0%
0%
141.0838%
0%
299.2508%
0%
65.4293%
326.7572%
163.4721%
4.4925%
461.0879%
285.801%
456.3183%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.